Consensus statement of the Spanish Society of Internal Medicine and the Spanish Society of Medical Oncology on secondary thromboprophylaxis in patients with cancer

Up to 20% of cancer patients will develop some manifestation of venous thromboembolic disease (VTD) during their clinical course. VTD greatly impacts morbidity, mortality, quality of life and pharmaceutical expenditure. In addition, both thrombotic relapse and major haemorrhages derived from VTD tre...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Transl Oncol
Autori principali: Quintanar, T., Font, C., Gallardo, E., Barba, R., Obispo, B., Díaz-Pedroche, C.
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer International Publishing 2020
Soggetti:
Special Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7979662/
https://ncbi.nlm.nih.gov/pubmed/32885400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12094-020-02477-6
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi